eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | pulmonary arterial hypertension |
| Comorbidity | C0020542|pulmonary hypertension |
| Sentences | 7 |
| PubMedID- 20677289 | pulmonary arterial hypertension (pah) associated with portal hypertension [portopulmonary hypertension (pphtn)] occurs in 2% to 10% of patients with advanced liver disease and carries a very poor prognosis without treatment. |
| PubMedID- 25223406 | pulmonary hypertension, including pulmonary arterial hypertension (pah), is a serious disease in children, but few clinical studies have been conducted to evaluate treatment regimens in this population. |
| PubMedID- 22482042 | Following these encouraging findings, a clinical study was performed to evaluate the short-term safety profile of bay 63-2561 (riociguat) to determine the tolerability and efficacy in patients with moderate to severe pulmonary hypertension (ph) due to pulmonary arterial hypertension, distal chronic thromboembolic ph, or ph with mild to moderate interstitial lung disease [134]. |
| PubMedID- 25902784 | The dataset was divided into three groups (fig.1): those with normal pulmonary hemodynamics (nph group), those whose hemodynamics met the 5th world symposium on pulmonary hypertension definition of pulmonary arterial hypertension (pah group) (hoeper et al. |
| PubMedID- 24015332 | [86] further studies will be required to fully understand the contributions of microparticles to pulmonary arterial hypertension (pah), but with pulmonary hypertension being a devastating disease that is difficult to detect prior to patient decline, these studies suggest that microparticles could potentially serve as biomarkers for early detection of the disease and further our understanding of the pathogenesis of pah. |
| PubMedID- 22086457 | Background: candidates for orthotopic liver transplantation (olt) often have porto-pulmonary hypertension (pphtn) with pulmonary arterial hypertension (pah). |
| PubMedID- 23319544 | Chronic exposure to cold caused pulmonary arterial hypertension (cold-induced pulmonary hypertension [ciph]) and increased phosphodiesterase-1c (pde-1c) expression in pulmonary arteries (pas) in rats. |
Page: 1